Post on 09-Jul-2020
conferenceseries.com Tentative Agenda
World Summit on
Hematology and Cell Therapy Theme:“AChallengingexplorationon Hematology
and Cell Therapy”
Program Manager
47 Churchfield road, London
W3 6AY. +44-800-098-8455
Email: asianematology@scimedconference.com
https://hematology.healthconferences.org/
Aug 07-08, 2020
Osaka, Japan
Tentative Agenda Asian Hematology 2020
Day 1 08:00-09:00 CONFERENCE ENROLLMENT
09:00-09:15 WELCOME NOTE
Exhibitors can reach the stall @ 9:00 AM simultaneously with sessions
DISTINGUISHED LECTURES
09:15-10:45
Keynote Lecture 1
Keynote Lecture 2
Keynote Lecture 3
Panel Discussions/Group Picture
Refreshments & Ideas Fair: 10:45-11:00
11:00-12:20 Workshop/Symposia
SESSION INTRODUCTION
SPEAKER SESSION
2 Speakers (20 Mins Each)
12:20-13:00 Speaker Presentation 1
Speaker Presentation 2
Lunch & Networking 13:00-13:50
SPEAKER SESSION (Cont… )
7 Speaker talks (20 Mins Each)
13:50-16:10
Speaker Presentation 3
Speaker Presentation 4
Speaker Presentation 5
Speaker Presentation 6
Speaker Presentation 7
Speaker Presentation 8
Speaker Presentation 9
Refreshments & Ideas Fair 16:10-16:25
SPEAKER SESSION (Cont… )
16:25-18:05
Speaker Presentation 10
Speaker Presentation 11
Speaker Presentation 12
Speaker Presentation 13
Speaker Presentation 14
Gala Drinks & Closing Remarks
Asian Hematology 2020
Day 2 08:30-09:15 CONFERENCE ENROLLMENT
SESSION INTRODUCTION
Exhibitors stall opens @ 9:30 AM simultaneously with sessions
DISTINGUISHED LECTURES
09:15-10:45
Keynote Lecture 4
Keynote Lecture 5
Keynote Lecture 6
Panel Discussions/Group Picture
Refreshments & Ideas Fair: 10:45-11:00
11:00-12:20 Workshop/Symposia
SESSION INTRODUCTION
SPEAKER SESSION
2 Speakers (20 Mins Each)
12:20-13:00 Speaker Presentation 1
Speaker Presentation 2
Lunch & Networking 13:00-13:50
SPEAKER SESSION (Cont… )
7 Speaker talks (20 Mins Each)
13:50-16:10
Speaker Presentation 17
Speaker Presentation 18
Speaker Presentation 19
Speaker Presentation 20
Speaker Presentation 21
Speaker Presentation 22
Speaker Presentation 23
Refreshments & Ideas Fair 16:10-16:25
POSTER SESSION/SPEAKER SESSION
5 Speaker talks (20 Mins Each)
16:25-18:05
Speaker Presentation 24
Speaker Presentation 25
Speaker Presentation 26
Speaker Presentation 27
Speaker Presentation 28
Gala Drinks & Closing Remarks
conferenceseries.com 1444th Conference Scientific Program
11th International Conference on
Hematology & Hematological Oncology November 08-09, 2017 | Las Vegas, USA
Bethlehem Solomon
Decision Resource Group, USA
Conferenceseries LLC - America
One Commerce Center-1201, Orange St. #600, Wilmington, Zip 19899, Delaware, USA P: +1-702-508-5200, F: +1-650-618-1417
Conferenceseries Ltd - UK Kemp House, 152 City Road, London EC1V 2NX Toll Free: +1-800-216-6499
Thank You for supporting Hematology & Hematological Oncology 2017
Moderator
09:00-09:30 Registrations
Conference Hall - Copa Room C
Opening Ceremony
10:40-11:10
Title: Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia
in the era of tyrosine kinase inhibitor therapy
Shimin Hu, The University of Texas MD Anderson Cancer Center, USA
Title: Autophagy in hematopoiesis and leukemogenesis Jianrong Wang, Hematology Center of Cyrus Tang Medical Institute, China
Title: The development of LPPC in PAS in Blood Transfusion Centre: Faculty of 11:55-12:35
12:35-13:05
Medicine Khon Kaen University, Thailand
Jongkol Akahat, Blood Transfusion Centre, Thailand
Title: Global incidence and prevalence of acute lymphoblastic leukemia: A 10-year
forecast Bethlehem Solomon, Decision Resources Group, USA
14:00-14:30
14:30-15:00
Title: In Vitro and In Vivo evidences of sickling reversal induced by rehydration with high K+- Isotonic solution
Olutayo Ifedayo Ajayi, University of Benin, Nigeria
Title: Altered avidity to and antigenic reactions induced by malaria parasitaemia
Nigerian subjects
Chinedu Kingsley Dike, University of Benin, Nigeria Title: Catastrophic antiphospholipid syndrome and sarcoidosis: A case report Nova Thomas John, Hartford Hospital, USA
Title: Integrating new treatment options into the management of adult ITP James Granfortuna, University of North Carolina Medical Center at Chapel Hill, USA
16:15-16:45
Title: Haematological profile and ascorbate deficiency among children of African
descent with protein energy malnutrition in Sokoto, North Western Nigeria
Erhabor Osaro, Usmanu Danfodiyo University Sokoto, Nigeria
Title: Altered leucocyte functions in HIV infected subjects Rosemary Omomo Ekpeh, University of Benin, Nigeria
Title: Direct antiglobulin reactions in plasmodium falciparum parasitized patients in 17:15-17:45 Sokoto, North Western Nigeria
Augustine Okwesili, Usmanu Danfodiyo University, Nigeria Panel Discussion
Page 2
Panel Discussion
Lunch Break 13:05-14:00 @ Renaissance III
Panel Discussion
Networking & Refreshment Break 11:10-11:25 @ Foyer
Day 1 November 08, 2017
Keynote Forum
Sessions: Hematology | Hematological Oncology | Hematology : Case Report
09:55-10:00 Introduction
10:00-10:40 Title: Luminescence reveals the cause of diabetes 1, 2 and 3 (Alzheimer’s Disease)
Knox Van Dyke, West Virginia University Medical School, USA
Session Introduction
Session Chair: Tomaz Kozak, Charles University, Czech Republic
conferenceseries.com 09:30-09:55
Networking & Refreshment Break 16:00-16:15 @ Foyer
Group Photo
Panel Discussion
11:25-11:55
15:00-15:30
15:30-16:00
16:45-17:15
Page 3
Conference Hall - Copa Room C
10:40-11:10
Title: Psychiatric comorbidities are associated with significantly increased cost of care
and healthcare utilization in multiple myeloma (MM) patients
Sikander Ailawadhi, Mayo Clinic, USA
11:25-11:55
11:55-12:25
12:25-12:55
Title: Lupus nephritis masquerading as hemophagocytic lymphohistoiocytosis
Nova Thomas John, Hartford Hospital, USA
The many faces of thrombotic microangiopathies
James Granfortuna, University of North Carolina Medical Center at Chapel Hill, USA Title:
Chimeric antigen receptors (CARs) engineered control adverse immune responses
David W Scott, Uniformed Services University of the Health Sciences, USA
13:45-14:15
14:15-14:45
14:45-15:15
15:15-15:45
Title: Black lung disease is mostly caused by silica toxicity and silica toxicity is caused
by contamination with calcium
Knox Van Dyke, West Virginia University Medical School, USA
Title: Systemic mastocytosis: Analysis of diagnostic marker compartments and the
course of the disease prediction
Tomas Kozak, Charles University, Czech Republic
Screening and identification of an aptamer to the HL-60 cell line of Acute Promyelocytic
Leukemia from a specific human ssDNA library
Nabusige Jean Brenda Gesa, Makerere University, Uganda
Title: L- Arginine levels among hypertensive patient of African Descent in Sokoto, North
Western Nigeria
Erhabor Osaro, Usmanu Danfodiyo University, Nigeria
Title: Antiphopholipid antibody syndrome and obstetric anesthesia Uma Hariharan, Dr. Ram Manohar Lohia Hospital, India
P 01 Title: Improving patient outcomes in the neutropenic population using the culture buddy system
Dustin Khoshreza, University of Kentucky, USA
P 02 Title: Myocardial infarction caused by Triple-Hit Lymphoma
Hermon Amanuel, Darent Valley Hospital, UK Title: The unit cost of leukocyte-depleted red blood cells concentrates in Blood
P 03
P 04
Transfusion Centre, Faculty of Medicine, Khon Kaen University, Thailand Uthenas Larsaeng, Blood Transfusion Centre, Thailand Title: The pilot study of evaluation of leukocyte-depleted platelet concentrates by
Autostop TM BC filter at Blood Transfusion Centre, Faculty of Medicine, Khon Kaen
University, Thailand
Nuanchan Mungkhunkhamchaw, Blood Transfusion Centre, Thailand
P 05 Title: Acute megakaryoblastic leukaemia (FAB M7)
Ojo Omotola Toyin, Olabisi Onabanjo University Teaching Hospital, Nigeria
P 06 Title: The complete blood count and anemia classification: A study in Southern Ethiopia
Misganaw Birhaneselassie, Hawassa University College of Medicine and Health Sciences, Ethiopia
Panel Discussion Thanks Giving & Closing Ceremony
Panel Discussion
Panel Discussion
Day 2 November 09, 2017
Keynote Forum
Sessions: HemaUtoSlAogy | Blood Disorders | Immunology | Blood Based Products
10:00-10:40 Title: Cytogenetics-based risk prediction of blastic transformation of chronic myeloid
leukemia treated with tyrosine kinase inhibitors
Shimin Hu, The University of Texas MD Anderson Cancer Center,
Session Introduction
Session Chairs: Tomaz Kozak, Charles University, Czech Republic James Granfortuna, University of North Carolina Medical Center at Chapel Hill, USA
Networking & Refreshment Break 15:45-16:00 @ Foyer Video Presentation
Panel Discussion Poster Presentations 16:30-17:30 @ Foyer/Chairman Room
Poster Judge: David W Scott, Uniformed Services University of the Health Sciences, USA
Lunch Break 12:55-13:45 @ Renaissance III
Networking & Refreshment Break 11:10-11:25 @ Foyer
16:00-16:30